Outpatients with acute SVT of at least @ cm in length of the internal or external saphenous veins or their collaterals were randomized in a double blind fashion to receive either parnaparin @ UI aXa od for ten days followed by placebo for @ days or @ UI aXa od for ten days followed by @ UI aXa od for @ days or @ UI aXa od for @ days .